PMID: 7930545Jun 1, 1994Paper

The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience

The Journal of Hospital Infection
I R Hudson


Staphylococcal infections remain an important cause of morbidity and mortality. Methicillin-resistant Staphylococcus aureus (MRSA) present a particular problem because of the costs of treatment and containing outbreaks. The role of nasal carriage of staphylococci in the epidemiology of staphylococcal infection has been recognized for over 30 years. Until recently, eradication of nasal carriage of S. aureus has proved difficult, with a variety of topical and systemic agents yielding poor results with either little discernible effect on nasal carriage or rapid recolonization. Mupirocin is a novel topical antibiotic with excellent antibacterial activity against staphylococci, including MRSA. Intranasal administration of calcium mupirocin has achieved excellent results in the eradication of nasal carriage of S. aureus and producing an associated reduction in S. aureus infection in a variety of clinical settings, including MRSA outbreaks, neonatal nurseries, haemodialysis, cardiothoracic surgery and familial staphylococcal infections. This article reviews the efficacy and safety of intranasal mupirocin in the prevention of staphylococcal infections.


Nov 1, 1992·The Journal of Antimicrobial Chemotherapy·T H FarmerS W Elson
Sep 1, 1991·The Journal of Hospital Infection·B Slocombe, C Perry
Sep 1, 1991·The Journal of Hospital Infection·M W Casewell, R L Hill
Jan 30, 1992·The New England Journal of Medicine·R P Wenzel
Oct 1, 1991·Journal of Biomedical Materials Research·S MuralidharanL B McGrath
Sep 16, 1991·The American Journal of Medicine·R P WenzelM A Pfaller
Dec 1, 1990·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·P B HeczkoU Hoeffler
May 1, 1990·Journal of the American Academy of Dermatology·J A MoyD M Carter
Apr 1, 1990·The Journal of Antimicrobial Chemotherapy·B D Cookson
Aug 1, 1989·The Journal of Hospital Infection·M BulandaB Heczko
Mar 1, 1986·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Jan 1, 1988·The Journal of Antimicrobial Chemotherapy·G E Smith, C T Kennedy
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R SutherlandA R White
Jul 1, 1993·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M C LaytonJ E Patterson

❮ Previous
Next ❯


Mar 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KretschmarH Hof
Oct 20, 1998·The Journal of Hospital Infection·S Mehtar
Apr 4, 2002·Diagnostic Microbiology and Infectious Disease·Rosana Barreto Rocha FerreiraKátia Regina Netto dos Santos
Nov 3, 2001·International Journal of Antimicrobial Agents·A N ManiatisA Agel
Jul 23, 2004·The Journal of Molecular Diagnostics : JMD·Suzanne M PauleLance R Peterson
Jan 25, 2003·Surgical Infections·Joseph A PaladinoJerome J Schentag
Oct 13, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Yusuf OnlenOzkan Aslantas
Sep 4, 2008·The Journal of Antimicrobial Chemotherapy·Xavier MalaviolleMarc J Struelens
Sep 30, 2008·The Journal of Antimicrobial Chemotherapy·A LoefflerD H Lloyd
Apr 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christopher Thiam-Seong LimMarjorie Wai-Yin Foo
Jul 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christopher Thiam-Seong LimMarjore Wai-Yin Foo
Sep 22, 2001·Protein Science : a Publication of the Protein Society·X QiuR L Jarvest
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Urs A OchsnerIan A Critchley
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Julian Gregston HurdleIan Chopra
Jul 27, 2007·Journal of Clinical Microbiology·Sabine Ridder-SchaphornBarbara C Kahl
May 13, 2004·Postgraduate Medical Journal·S ChauhanS S Chauhan
Oct 13, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Annabelle N ChuaEileen D Brewer
Mar 10, 1998·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·B BellmanW R Bebell
Jul 30, 2014·Glycoconjugate Journal·Prakash ParajuliJae Kyung Sohng
Sep 12, 2014·North American Journal of Medical Sciences·Parul ChaturvediLoveleena Agarwal
Oct 28, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rajeshwari NairMarin L Schweizer
Feb 18, 2016·Current Infectious Disease Reports·Sanjay Verma
Oct 4, 2008·Best Practice & Research. Clinical Anaesthesiology·William J MauermannRodney L Thompson
Jun 27, 2012·Veterinary Dermatology·Ralf S MuellerRoss Bond
Dec 9, 2015·Journal of Research in Pharmacy Practice·Loveleena AgarwalAmitabh Agarwal
Feb 1, 1995·The Journal of Hospital Infection·R R MarplesB D Cookson
Mar 3, 2009·Pharmacotherapy·Kevin W McConeghyKerry L LaPlante
Oct 24, 2014·Journal of Hepato-biliary-pancreatic Sciences·Hidetoshi NittaHideo Baba
Oct 29, 2011·Neuroimaging Clinics of North America·Vikas AgarwalRakesh K Gupta
Oct 1, 2008·Current Opinion in Microbiology·Vincent A Fischetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.